These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31888612)

  • 1. An analysis about heterogeneity among cancers based on the DNA methylation patterns.
    Liu Y; Gu Y; Su M; Liu H; Zhang S; Zhang Y
    BMC Cancer; 2019 Dec; 19(1):1259. PubMed ID: 31888612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
    Shi S; Xu M; Xi Y
    Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
    Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
    Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Network-Based Analysis of Colorectal Cancer Identifies Novel Prognostic Factors and an Integrative Prognostic Index.
    Hou X; He X; Wang K; Hou N; Fu J; Jia G; Zuo X; Xiong H; Pang M
    Cell Physiol Biochem; 2018; 49(5):1703-1716. PubMed ID: 30248669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients.
    Figueroa JD; Yang H; Garcia-Closas M; Davis S; Meltzer P; Lissowska J; Horne HN; Sherman ME; Lee M
    Breast Cancer Res Treat; 2015 Apr; 150(2):457-466. PubMed ID: 25773928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic signature in cancer based on DNA methylation interaction network.
    Hu WL; Zhou XH
    BMC Med Genomics; 2017 Dec; 10(Suppl 4):63. PubMed ID: 29322932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
    Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
    J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers.
    Robles AI; Arai E; Mathé EA; Okayama H; Schetter AJ; Brown D; Petersen D; Bowman ED; Noro R; Welsh JA; Edelman DC; Stevenson HS; Wang Y; Tsuchiya N; Kohno T; Skaug V; Mollerup S; Haugen A; Meltzer PS; Yokota J; Kanai Y; Harris CC
    J Thorac Oncol; 2015 Jul; 10(7):1037-48. PubMed ID: 26134223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
    Wu ZH; Tang Y; Zhou Y
    Cancer Control; 2021; 28():1073274820988519. PubMed ID: 33504182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
    Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
    Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
    Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
    Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
    Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis related miRNAs, DNA methylation, and epigenetic interactions in lung adenocarcinoma.
    Liu H; Zhao H
    Neoplasma; 2019 May; 66(3):487-493. PubMed ID: 30868896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes.
    Cheol Kim D; Thorat MA; Lee MR; Cho SH; Vasiljević N; Scibior-Bentkowska D; Wu K; Ahmad AS; Duffy S; Cuzick JM; Lorincz AT
    Cancer Biomark; 2012; 11(2-3):75-88. PubMed ID: 23011154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.